We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IMNM market cap is 637.53M. The company's latest EPS is USD -2.4996 and P/E is -5.98.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.36M | 4.26M | 3.57M | 3.83M | 1.03M |
| Operating Income | -4.47M | -5.77M | -4.63M | -94.65M | -132.3M |
| Net Income | -4.27M | -5.56M | -4.35M | -92.63M | -129.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 503k | 0 | 14.02M |
| Operating Income | -10.35M | -12.26M | -24.7M | -36.9M | -109.53M |
| Net Income | -10.44M | -17.84M | -24.71M | -37.52M | -106.81M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.11M | 41.44M | 93.16M | 148.54M | 319.75M |
| Total Liabilities | 34.25M | 32.1M | 87.09M | 28.66M | 34.18M |
| Total Equity | 13.86M | 9.34M | 6.08M | 119.88M | 285.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.06M | 44.53M | 57.93M | 24.05M | 148.54M |
| Total Liabilities | 1.8M | 3.18M | 9.74M | 7.39M | 28.66M |
| Total Equity | -35.63M | 41.35M | 48.19M | 16.65M | 119.88M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 24.17M | 18.51M | 9.89M | -7.57M | -11.17M |
| Investing | -106k | -446k | -482k | -30.48M | -37.23M |
| Financing | 34k | 34k | 60.91M | 116.41M | 219.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.6M | -12.13M | -18.23M | -28.69M | -7.57M |
| Investing | -233k | -586k | -79k | -248k | -30.48M |
| Financing | 10.77M | 49.94M | 27.77M | 32k | 116.41M |
| Market Cap | 637.53M |
| Price to Earnings Ratio | -5.98 |
| Price to Sales Ratio | 45.53 |
| Price to Cash Ratio | 6.47 |
| Price to Book Ratio | 5.33 |
| Dividend Yield | - |
| Shares Outstanding | 42.73M |
| Average Volume (1 week) | 593.92k |
| Average Volume (1 Month) | 811.3k |
| 52 Week Change | 184.73% |
| 52 Week High | 30.958 |
| 52 Week Low | 5.20 |
| Spread (Intraday) | 5.26 (26.07%) |
| Company Name | Immunome Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.immunome.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
